I wouldn't be so cynical to suggest that PWS Ph2 pause is anything to do with not fitting in to a takeover timeline.
The idea you would delay and screw potential beneficiaries of treatment merely because you expect to be taken over before Ph2 completed would seem pretty amoral. I would take the reason for the pause as the stated reason, not a guessed one. Any potential acquirer would rather see an indication further down the road to approval than not, so it doesn't even make sense to assume that is why the pause.
I wouldn't be so cynical to suggest that PWS Ph2 pause is...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.27 |
Change
0.650(3.15%) |
Mkt cap ! $2.718B | |||
| Open | High | Low | Value | Volume |
| $20.84 | $21.56 | $20.76 | $7.760M | 364.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1378 | $21.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.29 | 218 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |